Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1985-11-5
|
pubmed:abstractText |
About 20 cases of acquired C1 esterase inhibitor deficiency have been reported in association with malignant lymphomas. We describe 3 such patients. The 3 patients studied were asymptomatic and had low C1q level. Danazol administration resulted in an increase of C1 esterase inhibitor in 2 patients. The complement activation in acquired C1 esterase inhibitor deficiency could be explained by interaction with pathological cells of the spleen, the blood or the bone-marrow. The mechanism of decrease of C1 INH is discussed.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0248-8663
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
266-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4048687-Aged,
pubmed-meshheading:4048687-Complement C1 Inactivator Proteins,
pubmed-meshheading:4048687-Complement System Proteins,
pubmed-meshheading:4048687-Danazol,
pubmed-meshheading:4048687-Female,
pubmed-meshheading:4048687-Humans,
pubmed-meshheading:4048687-Lymphoproliferative Disorders,
pubmed-meshheading:4048687-Male,
pubmed-meshheading:4048687-Middle Aged,
pubmed-meshheading:4048687-Plasmapheresis,
pubmed-meshheading:4048687-Time Factors
|
pubmed:year |
1985
|
pubmed:articleTitle |
[Acquired C1 esterase inhibitor deficiency and lymphoproliferative syndromes].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|